Anzeige
Mehr »
Donnerstag, 02.10.2025 - Börsentäglich über 12.000 News
Starkes Upside-Potenzial: Wachstumsstory mit starken Gehalten und großem Explorationspotenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A417GR | ISIN: US37148K2096 | Ticker-Symbol:
NASDAQ
02.10.25 | 22:00
6,140 US-Dollar
+1,49 % +0,090
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
GENERATION BIO CO Chart 1 Jahr
5-Tage-Chart
GENERATION BIO CO 5-Tage-Chart

Aktuelle News zur GENERATION BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.08.Generation Bio stock price target raised to $10 from $9 at Canaccord3
18.08.Canaccord hebt Kursziel für Generation Bio auf 10 US-Dollar an8
14.08.JMP Securities reiterates Market Perform rating on Generation Bio stock5
14.08.JMP Securities hält an "Market Perform"-Rating für Generation Bio fest11
13.08.Generation Bio soars as it explores strategic alternatives7
13.08.Wedbush downgrades Generation Bio stock rating to Neutral amid restructuring17
12.08.Generation Bio Co. - 10-Q, Quarterly Report11
12.08.Generation Bio Co. - 8-K, Current Report1
GENERATION BIO Aktie jetzt für 0€ handeln
18.07.Generation Bio to implement 1-for-10 reverse stock split7
18.07.Generation Bio Co. - 8-K, Current Report5
18.07.Generation Bio Co.: Generation Bio Announces 1-for-10 Reverse Stock Split397CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases...
► Artikel lesen
07.07.Generation Bio Co.: Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)206CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases...
► Artikel lesen
05.06.Generation Bio Co. - 8-K, Current Report3
09.05.Where Generation Bio Stands With Analysts47
07.05.Generation Bio GAAP EPS of -$0.22, revenue of $8.72M2
07.05.Generation Bio Co. - S-8, Securities to be offered to employees in employee benefit plans1
07.05.Generation Bio Co. - 8-K, Current Report-
07.05.Generation Bio Co.: Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results653- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA...
► Artikel lesen
13.03.Generation Bio Co.: Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results230- Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases - Lead target and indication to be announced MY 2025 ...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,5